These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12701115)

  • 1. Effects of human mast cell tryptase and eosinophil granule proteins on the kinetics of blood clotting.
    Samoszuk M; Corwin M; Hazen SL
    Am J Hematol; 2003 May; 73(1):18-25. PubMed ID: 12701115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell tryptase activates peripheral blood eosinophils to release granule-associated enzymes.
    Vliagoftis H; Lacy P; Luy B; Adamko D; Hollenberg M; Befus D; Moqbel R
    Int Arch Allergy Immunol; 2004 Nov; 135(3):196-204. PubMed ID: 15467372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil granule proteins activate human heart mast cells.
    Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
    J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
    Cregar L; Elrod KC; Putnam D; Moore WR
    Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and characteristics of mast cell tryptase and eosinophilic cationic protein from human gut mucosa in gastrointestinal allergy.
    Raithel M; Pacurar A; Winterkamp S; Dalbay S; Ell C; Hahn EG
    Monogr Allergy; 1996; 32():143-56. PubMed ID: 8813193
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of tryptase and chymase induced nucleated cell infiltration by proteinase inhibitors.
    He SH; Chen HQ; Zheng J
    Acta Pharmacol Sin; 2004 Dec; 25(12):1677-84. PubMed ID: 15569415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.
    He S; Peng Q; Walls AF
    J Immunol; 1997 Dec; 159(12):6216-25. PubMed ID: 9550425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve growth factor and eosinophils in inflamed juvenile conjunctival nevus.
    Levi-Schaffer F; Micera A; Zamir E; Mechoulam H; Puxeddu I; Piliponsky AM; Aloe L; Pe'er J
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1850-6. PubMed ID: 12036989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH; Chen P; Chen HQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
    He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
    Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
    J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of active monomers from tetrameric human beta-tryptase.
    Fajardo I; Pejler G
    Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell tryptase: a review of its physiology and clinical significance.
    Payne V; Kam PC
    Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal allergen challenge and immunotherapy control.
    Palma-Carlos AG; Palma-Carlos ML; Branco-Ferreira M; Spinola A; Santos MC; Lopes-Pregral A
    Allerg Immunol (Paris); 1998 May; 30(5):153-6. PubMed ID: 9657024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression.
    Cairns JA; Walls AF
    J Immunol; 1996 Jan; 156(1):275-83. PubMed ID: 8598474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
    Addington AK; Johnson DA
    Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors.
    Fukuoka Y; Schwartz LB
    Biochemistry; 2004 Aug; 43(33):10757-64. PubMed ID: 15311937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.